OneMedNet Corporation (NASDAQ:ONMD) Short Interest Update

OneMedNet Corporation (NASDAQ:ONMD) was the target of a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 423,841 shares, an increase of 93.6% from the November 30th total of 218,963 shares. Approximately 1.5% of the company’s shares are short sold. Based on an average daily volume of 763,417 shares, the days-to-cover ratio is presently 0.6 days. Based on an average daily volume of 763,417 shares, the days-to-cover ratio is presently 0.6 days. Approximately 1.5% of the company’s shares are short sold.

OneMedNet Stock Performance

ONMD traded down $0.08 during trading on Monday, reaching $1.20. 181,998 shares of the company traded hands, compared to its average volume of 5,342,153. The company has a market cap of $60.95 million, a P/E ratio of -23.90 and a beta of 1.10. OneMedNet has a 12-month low of $0.30 and a 12-month high of $4.22. The firm has a fifty day simple moving average of $1.66 and a 200 day simple moving average of $1.16.

OneMedNet (NASDAQ:ONMD) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.18 million during the quarter.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of OneMedNet in a research report on Tuesday, October 14th. Wall Street Zen raised OneMedNet to a “hold” rating in a report on Friday, September 26th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Insider Buying and Selling at OneMedNet

In related news, Director Eric Casaburi purchased 10,000 shares of OneMedNet stock in a transaction that occurred on Wednesday, October 15th. The shares were bought at an average price of $3.05 per share, for a total transaction of $30,500.00. Following the completion of the transaction, the director directly owned 65,475 shares of the company’s stock, valued at $199,698.75. This represents a 18.03% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Aaron Green sold 64,767 shares of the firm’s stock in a transaction on Wednesday, October 22nd. The shares were sold at an average price of $2.23, for a total value of $144,430.41. Following the transaction, the chief executive officer directly owned 1,865,658 shares of the company’s stock, valued at $4,160,417.34. This represents a 3.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 46.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Ashton Thomas Private Wealth LLC bought a new stake in shares of OneMedNet in the 3rd quarter worth about $25,000. Exencial Wealth Advisors LLC boosted its position in shares of OneMedNet by 3.1% during the second quarter. Exencial Wealth Advisors LLC now owns 1,491,862 shares of the company’s stock valued at $851,000 after buying an additional 45,448 shares during the period. Finally, Correct Capital Wealth Management bought a new position in shares of OneMedNet during the third quarter valued at approximately $4,910,000. Institutional investors own 0.95% of the company’s stock.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.